AtriCure annual gross margin
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
AtriCure's gross margin was 74.98% for fiscal 2025.
View full AtriCure company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 74.98% | +0.29 pp |
| 2024 | 2024-12-31 | 74.69% | −0.55 pp |
| 2023 | 2023-12-31 | 75.23% | +0.79 pp |
| 2022 | 2022-12-31 | 74.44% | −0.60 pp |
| 2021 | 2021-12-31 | 75.04% | +2.75 pp |
| 2020 | 2020-12-31 | 72.29% | −1.51 pp |
| 2019 | 2019-12-31 | 73.80% | +0.83 pp |
| 2018 | 2018-12-31 | 72.97% | +0.76 pp |
| 2017 | 2017-12-31 | 72.21% | +0.58 pp |
| 2016 | 2016-12-31 | 71.63% | +0.05 pp |
| 2015 | 2015-12-31 | 71.58% | +1.08 pp |
| 2014 | 2014-12-31 | 70.50% | −2.24 pp |
| 2013 | 2013-12-31 | 72.74% | +1.54 pp |
| 2012 | 2012-12-31 | 71.20% | −1.78 pp |
| 2011 | 2011-12-31 | 72.97% | −3.95 pp |
| 2010 | 2010-12-31 | 76.92% | +0.30 pp |
| 2009 | 2009-12-31 | 76.62% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 77.23% | +2.69 pp |
| Q1 2026 | 2026-03-31 | 77.39% | +2.46 pp |
| Q4 2025 | 2025-12-31 | 74.97% | +0.45 pp |
| Q3 2025 | 2025-09-30 | 75.47% | +0.59 pp |
| Q2 2025 | 2025-06-30 | 74.54% | −0.15 pp |
| Q1 2025 | 2025-03-31 | 74.93% | +0.27 pp |
| Q4 2024 | 2024-12-31 | 74.53% | −0.39 pp |
| Q3 2024 | 2024-09-30 | 74.88% | −0.27 pp |
| Q2 2024 | 2024-06-30 | 74.69% | −1.68 pp |
| Q1 2024 | 2024-03-31 | 74.66% | +0.21 pp |
| Q4 2023 | 2023-12-31 | 74.91% | +0.94 pp |
| Q3 2023 | 2023-09-30 | 75.15% | +1.02 pp |
| Q2 2023 | 2023-06-30 | 76.38% | +1.23 pp |
| Q1 2023 | 2023-03-31 | 74.45% | −0.10 pp |
| Q4 2022 | 2022-12-31 | 73.97% | −1.17 pp |
| Q3 2022 | 2022-09-30 | 74.13% | +0.01 pp |
| Q2 2022 | 2022-06-30 | 75.14% | −0.62 pp |
| Q1 2022 | 2022-03-31 | 74.55% | −0.59 pp |
| Q4 2021 | 2021-12-31 | 75.14% | +1.62 pp |
| Q3 2021 | 2021-09-30 | 74.12% | +0.46 pp |
| Q2 2021 | 2021-06-30 | 75.76% | +8.03 pp |
| Q1 2021 | 2021-03-31 | 75.14% | +2.09 pp |
| Q4 2020 | 2020-12-31 | 73.52% | +0.50 pp |
| Q3 2020 | 2020-09-30 | 73.66% | −0.17 pp |
| Q2 2020 | 2020-06-30 | 67.74% | −6.77 pp |
| Q1 2020 | 2020-03-31 | 73.06% | −0.83 pp |
| Q4 2019 | 2019-12-31 | 73.02% | +0.06 pp |
| Q3 2019 | 2019-09-30 | 73.83% | +1.85 pp |
| Q2 2019 | 2019-06-30 | 74.51% | +1.00 pp |
| Q1 2019 | 2019-03-31 | 73.88% | +0.46 pp |
| Q4 2018 | 2018-12-31 | 72.96% | +2.00 pp |
| Q3 2018 | 2018-09-30 | 71.98% | −1.37 pp |
| Q2 2018 | 2018-06-30 | 73.51% | +1.54 pp |
| Q1 2018 | 2018-03-31 | 73.42% | +0.71 pp |
| Q4 2017 | 2017-12-31 | 70.95% | +0.74 pp |
| Q3 2017 | 2017-09-30 | 73.35% | +1.70 pp |
| Q2 2017 | 2017-06-30 | 71.97% | −0.67 pp |
| Q1 2017 | 2017-03-31 | 72.71% | +0.60 pp |
| Q4 2016 | 2016-12-31 | 70.21% | −1.02 pp |
| Q3 2016 | 2016-09-30 | 71.65% | +0.12 pp |
| Q2 2016 | 2016-06-30 | 72.64% | +1.69 pp |
| Q1 2016 | 2016-03-31 | 72.10% | −0.62 pp |
| Q4 2015 | 2015-12-31 | 71.23% | +1.81 pp |
| Q3 2015 | 2015-09-30 | 71.53% | +0.72 pp |
| Q2 2015 | 2015-06-30 | 70.95% | +0.11 pp |
| Q1 2015 | 2015-03-31 | 72.73% | +1.66 pp |
| Q4 2014 | 2014-12-31 | 69.42% | −2.18 pp |
| Q3 2014 | 2014-09-30 | 70.81% | −2.08 pp |
| Q2 2014 | 2014-06-30 | 70.83% | −3.19 pp |
| Q1 2014 | 2014-03-31 | 71.06% | −1.43 pp |
| Q4 2013 | 2013-12-31 | 71.60% | +0.80 pp |
| Q3 2013 | 2013-09-30 | 72.89% | +1.33 pp |
| Q2 2013 | 2013-06-30 | 74.03% | +4.45 pp |
| Q1 2013 | 2013-03-31 | 72.50% | −0.47 pp |
| Q4 2012 | 2012-12-31 | 70.80% | +0.76 pp |
| Q3 2012 | 2012-09-30 | 71.56% | −1.26 pp |
| Q2 2012 | 2012-06-30 | 69.58% | −3.58 pp |
| Q1 2012 | 2012-03-31 | 72.97% | −3.09 pp |
| Q4 2011 | 2011-12-31 | 70.04% | −7.16 pp |
| Q3 2011 | 2011-09-30 | 72.82% | −6.30 pp |
| Q2 2011 | 2011-06-30 | 73.16% | — |
| Q1 2011 | 2011-03-31 | 76.06% | — |
| Q3 2010 | 2010-09-30 | 77.20% | — |
| Q2 2010 | 2010-06-30 | 79.12% | — |
Over the last five reported fiscal years, AtriCure's gross margin increased from 72.29% to 74.98%, a change of +2.68 percentage points. The latest reported quarter, Q2 2026, shows 77.23%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AtriCure filings at SEC.gov ↗